Cargando…

Efficacy of Cefquinome against Escherichia coli Environmental Mastitis Assessed by Pharmacokinetic and Pharmacodynamic Integration in Lactating Mouse Model

This work investigates the pharmacodynamic effectiveness of cefquinome against environmental Escherichia coli mastitis infection, following an intramammary administration. We established the pharmacokinetic and pharmacodynamic (PK/PD) model in lactating mice. The PK/PD parameters were identified to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yang, Fang, Jin-Tao, Sun, Jian, Zheng, Mei, Zhang, Qing, He, Jie-Shun, Liao, Xiao-Ping, Liu, Ya-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539083/ https://www.ncbi.nlm.nih.gov/pubmed/28824576 http://dx.doi.org/10.3389/fmicb.2017.01445

Ejemplares similares

Dose Assessment of Cefquinome by Pharmacokinetic/Pharmacodynamic Modeling in Mouse Model of Staphylococcus aureus Mastitis
por: Yu, Yang, et al.
Publicado: (2016)

In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion
por: Yu, Yang, et al.
Publicado: (2016)

The pharmacokinetics and pharmacodynamics of cefquinome against Streptococcus agalactiae in a murine mastitis model
por: Yang, Qingwen, et al.
Publicado: (2023)

Pharmacokinetic/Pharmacodynamic Correlation of Cefquinome Against Experimental Catheter-Associated Biofilm Infection Due to Staphylococcus aureus
por: Zhou, Yu-Feng, et al.
Publicado: (2016)

Pharmacokinetic and Pharmacodynamic Integration and Modeling of Enrofloxacin in Swine for Escherichia coli
por: Wang, Jianyi, et al.
Publicado: (2016)

Ex Vivo Pharmacokinetics and Pharmacodynamics Modeling and Optimal Regimens Evaluation of Cefquinome Against Bovine Mastitis Caused by Staphylococcus aureus
por: Jiang, Li-jie, et al.
Publicado: (2022)

Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against Actinobacillus pleuropneumoniae
por: Zhang, Longfei, et al.
Publicado: (2020)

Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome against Streptococcus equi subsp. equi in foals
por: Lee, Dong-Ha, et al.
Publicado: (2020)

Pharmacokinetics, bioavailability and dose assessment of Cefquinome against Escherichia coli in black swans (Cygnus atratus)
por: Zhao, Dong-Hao, et al.
Publicado: (2017)

In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis
por: Xiao, Xia, et al.
Publicado: (2015)

Fecal microbiome transplant from patients with lactation mastitis promotes mastitis in conventional lactating mice
por: Kong, Chao-Yue, et al.
Publicado: (2023)

Preparation of Cefquinome Sulfate Proliposome and its Pharmacokinetics in Rabbit
por: FU, Qiang, et al.
Publicado: (2013)

Escherichia coli Mastitis in Dairy Cattle: Etiology, Diagnosis, and Treatment Challenges
por: Goulart, Débora Brito, et al.
Publicado: (2022)

Pharmacokinetic and pharmacodynamic modeling of sarafloxacin against avian pathogenic Escherichia coli in Muscovy ducks
por: Yu, Yang, et al.
Publicado: (2017)

Pharmacokinetic–Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers
por: Sang, KaNa, et al.
Publicado: (2016)

Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle
por: Ahmad, Ijaz, et al.
Publicado: (2015)

QseBC is involved in the biofilm formation and antibiotic resistance in Escherichia coli isolated from bovine mastitis
por: Li, Wenchang, et al.
Publicado: (2020)

Pharmacokinetics and Pharmacodynamics of Fungal Defensin NZX Against Staphylococcus aureus-Induced Mouse Peritonitis Model
por: Zheng, Xueling, et al.
Publicado: (2022)

In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model
por: Zhang, Bingxu, et al.
Publicado: (2014)

Histidine Metabolism and IGPD Play a Key Role in Cefquinome Inhibiting Biofilm Formation of Staphylococcus xylosus
por: Zhou, Yong-hui, et al.
Publicado: (2018)

Efficacy of cefquinome and a combination of cloxacillin and ampicillin for treatment of dairy cows with Streptococcus agalactiae subclinical mastitis
por: Rossi, Rodolfo Santos, et al.
Publicado: (2019)

Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model
por: Gu, Mengxiao, et al.
Publicado: (2015)

Correlation of PK/PD Indices with Resistance Selection for Cefquinome against Staphylococcus aureus in an In Vitro Model
por: Li, Yafei, et al.
Publicado: (2016)

In vivo pharmacokinetic/Pharmacodynamic modeling of Enrofloxacin against Escherichia coli in broiler chickens
por: Xiao, Xia, et al.
Publicado: (2018)

Detection of Antibiotic Resistance in Feline-Origin ESBL Escherichia coli from Different Areas of China and the Resistance Elimination of Garlic Oil to Cefquinome on ESBL E. coli
por: Tong, Yin-Chao, et al.
Publicado: (2023)

Breastmilk microbiome changes associated with lactational mastitis and treatment with dandelion extract
por: Jin, Xinyan, et al.
Publicado: (2023)

Bacteriophage Cocktails Protect Dairy Cows Against Mastitis Caused By Drug Resistant Escherichia coli Infection
por: Guo, Mengting, et al.
Publicado: (2021)

Lactobacillus casei Zhang Counteracts Blood-Milk Barrier Disruption and Moderates the Inflammatory Response in Escherichia coli-Induced Mastitis
por: Zheng, Yuhui, et al.
Publicado: (2021)

Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against Escherichia coli in Pigs
por: Lei, Zhixin, et al.
Publicado: (2017)

Pharmacokinetics and pharmacodynamics of enrofloxacin treatment of Escherichia coli in a murine thigh infection modeling
por: Liu, Xuesong, et al.
Publicado: (2021)

Immune profiling of experimental murine mastitis reveals conserved response to mammary pathogenic Escherichia coli, Mycoplasma bovis, and Streptococcus uberis
por: Schneider, Peleg, et al.
Publicado: (2023)

Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model
por: Xiong, Mingpeng, et al.
Publicado: (2016)

Underlying mechanisms involved in the decrease of milk secretion during Escherichia coli endotoxin induced mastitis in lactating mice
por: Kobayashi, Ken, et al.
Publicado: (2013)

Frequently used therapeutic antimicrobials and their resistance patterns on Staphylococcus aureus and Escherichia coli in mastitis affected lactating cows
por: Rana, Eaftekhar Ahmed, et al.
Publicado: (2022)

Comparative Pharmacokinetics of Cefquinome (Cobactan 2.5%) following Repeated Intramuscular Administrations in Sheep and Goats
por: El-Hewaity, Mohamed, et al.
Publicado: (2014)

A physiologically based pharmacokinetic model to optimize the dosage regimen and withdrawal time of cefquinome in pigs
por: Mi, Kun, et al.
Publicado: (2023)

Detection and drug resistance profile of Escherichia coli from subclinical mastitis cows and water supply in dairy farms in Saraburi Province, Thailand
por: Hinthong, Woranich, et al.
Publicado: (2017)

Pharmacokinetic and pharmacodynamic properties of polymyxin B in Escherichia coli and Klebsiella pneumoniae murine infection models
por: van der Meijden, Aart, et al.
Publicado: (2023)

An Environmental Escherichia coli Strain Is Naturally Competent to Acquire Exogenous DNA
por: Riva, Francesco, et al.
Publicado: (2020)

Pharmacokinetic/Pharmacodynamic Integration to Evaluate the Changes in Susceptibility of Actinobacillus pleuropneumoniae After Repeated Administration of Danofloxacin
por: Zhang, Longfei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q1cs0f1at7v88ng91p9mrgn7mb